Analysis of the TCGA prostate cancer patient dataset filtered for patients who had undergone anti-hormonal therapy revealed a correlation between TLE3 expression and biochemical recurrence (p = 0.033, n = 65) (Figure 5C). The gene discussed is TLE3; the disease is prostate carcinoma.